Stock Earnings

Question 1

Vir Biotechnology Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Vir Biotechnology Incの総資産は$1,398で、純lossは$-521です。

Question 2

VIRの主要な財務比率は何ですか？

Accepted Answer

Vir Biotechnology Incの流動比率は5.63、純利益率は-704.05、1株当たり売上高は$0.54です。

Question 3

Vir Biotechnology Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Vir Biotechnology Inc largest revenue segment is Antibody-based Therapies, at a revenue of 74,205,000 in the most earnings release.For geography, United States is the primary market for Vir Biotechnology Inc, at a revenue of 74,205,000.

Question 4

Vir Biotechnology Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Vir Biotechnology Incの純lossは$-521です。

Question 5

Vir Biotechnology Incに負債はありますか？

Accepted Answer

yes、Vir Biotechnology Incの負債は248です。

Question 6

Vir Biotechnology Incの発行済株式数は何株ですか？

Accepted Answer

Vir Biotechnology Incの総発行済株式数は136.95株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	19	74	86	1,615	1,095	76
Revenue Growth (YoY)	-76%	-14%	-95%	47%	1,341%	850%
Cost of Revenue	0	0	2	146	65	--
Gross Profit	18	73	83	1,469	1,029	--
Selling, General & Admin	98	119	178	161	160	70
Research & Development	517	506	589	474	447	301
Operating Expenses	616	625	767	636	608	373
Other Non Operating Income (Expenses)	-1	-2	-8	4	-9	-4
Pretax Income	-549	-523	-628	754	549	-298
Income Tax Expense	0	-1	-13	238	21	0
Net Income	-550	-521	-615	515	528	-298
Net Income Growth	14%	-15%	-219%	-2%	-277%	71%
Shares Outstanding (Diluted)	138.44	136.24	134.13	134.8	133.4	119.2
Shares Change (YoY)	2%	2%	-1%	1%	12%	293%
EPS (Diluted)	-3.97	-3.83	-4.58	3.83	3.96	-2.51
EPS Growth	12%	-16%	-220%	-3%	-258%	-56%
Free Cash Flow	-466	-453	-800	1,595	-69	-197
Free Cash Flow Per Share	-3.36	-3.32	-5.96	11.83	-0.51	-1.65
Gross Margin	94.73%	98.64%	96.51%	90.95%	93.97%	--
Operating Margin	-3,142.1%	-745.94%	-795.34%	51.57%	38.35%	-390.78%
Profit Margin	-2,894.73%	-704.05%	-715.11%	31.88%	48.21%	-392.1%
Free Cash Flow Margin	-2,452.63%	-612.16%	-930.23%	98.76%	-6.3%	-259.21%
EBITDA	-586	-538	-665	839	425	-292
EBITDA Margin	-3,084.21%	-727.02%	-773.25%	51.95%	38.81%	-384.21%
D&A For EBITDA	11	14	19	6	5	5
EBIT	-597	-552	-684	833	420	-297
EBIT Margin	-3,142.1%	-745.94%	-795.34%	51.57%	38.35%	-390.78%
Effective Tax Rate	0%	0.19%	2.07%	31.56%	3.82%	0%

Vir Biotechnology Inc (VIR) Price

VIR Stock Price Chart

VIR Income

Follow-Up Questions